Journal
EUROPEAN JOURNAL OF HUMAN GENETICS
Volume 19, Issue 11, Pages 1122-1126Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/ejhg.2011.94
Keywords
genetic testing; children; direct-to-consumer; professional guidelines
Funding
- European Commission
- Canadian Institutes of Health Research
- Research Fund Flanders (FWO)
- Genome Canada
- Genome Quebec
Ask authors/readers for more resources
The genetic testing of minors within the direct-to-consumer (DTC) genetic testing (GT) context has been given relatively little attention. The issue of testing healthy children for diseases that would only develop in adulthood raises many important ethical, legal and social issues. As genetic testing is now available outside of the traditional health care system, often without even the intermediate of a health care professional, we surveyed 37 DTC GT companies regarding their policies for testing in children. Although the response rate is relatively low (35%, 13/37), our findings reveal that a clear majority of companies do perform genetic testing in minors. As such, companies testing for adult onset diseases are acting in contradiction of established professional guidelines, which state, among others, that, for predictive genetic testing, the availability of therapeutic or preventive measures is necessary for testing to be performed in asymptomatic minors. The community of stakeholders in children's health care and genetic testing should, therefore, decide which standards need to be upheld by DTC GT companies and ensure that these are met. European Journal of Human Genetics (2011) 19, 1122-1126; doi: 10.1038/ejhg.2011.94; published online 1 June 2011
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available